Medical Oddities: Dogs share our mortality markers - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

  • By

  • Teraya Smith

  • September 2, 2026

  • 5 min

Share

Clinical Scorecard: Medical Oddities: Dogs share our mortality markers

At a Glance

CategoryDetail
ConditionMortality markers in dogs
Key MechanismsBiochemical associations with all-cause mortality
Target PopulationCompanion dogs
Care SettingGeroscience research

Key Highlights

  • 17% of plasma metabolites linked to all-cause mortality in dogs
  • 23 metabolites met statistical significance for mortality association
  • 64% concordance in mortality associations between dogs and humans
  • Higher levels of specific metabolites linked to mortality in both species
  • Study involved 937 dogs over an average follow-up of 2.6 years

Guideline-Based Recommendations

Diagnosis

  • Assess plasma metabolites for mortality risk in dogs

Management

  • Monitor key metabolites associated with aging and renal function

Monitoring & Follow-up

  • Regular follow-up on identified metabolites over time

Risks

  • Potential shared aging biology between dogs and humans

Patient & Prescribing Data

Companion dogs in geroscience studies

Focus on biochemical markers for mortality assessment

Clinical Best Practices

  • Incorporate metabolite analysis in canine health assessments
  • Utilize findings to inform aging-related health management in dogs

Related Resources & Content

Original Source(s)

Medical Oddities: Dogs share our mortality markers

  • by Teraya Smith

  • September 2, 2026

Related Content

Neurogenic progression may falter in MDD

Postmortem multiomic analyses showed more quiescent neural stem cells and fewer neuroblasts, alongside broader hippocampal molecular changes.

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

Handwriting Kinematics Differentiate Cognitive Impairment

“Diagnostic differentiation emerged only under tasks imposing higher cognitive-motor demands.”